Liu, Ye Qi, Peter W. Nevin, and Jack L. Leahy. ␤-Cell adaptation in 60% pancreatectomy rats that preserves normoinsulinemia and normoglycemia. Am J Physiol Endocrinol Metab 278: E68-E73, 2000.-Islet ␤-cells are the regulatory element of the glucose homeostasis system. When functioning normally, they precisely counterbalance changes in insulin sensitivity or ␤-cell mass to preserve normoglycemia. This understanding seems counter to the dogma that ␤-cells are regulated by glycemia. We studied 60% pancreatectomy rats (Px) 4 wk postsurgery to elucidate the ␤-cell adaptive mechanisms. Nonfasting glycemia and insulinemia were identical in Px and sham-operated controls. There was partial regeneration of the excised ␤-cells in the Px rats, but it was limited in scope, with the pancreas ␤-cell mass reaching 55% of the shams (40% increase from the time of surgery). More consequential was a heightened glucose responsiveness of Px islets so that glucose utilization and insulin secretion per milligram of islet protein were both 80% augmented at normal levels of glycemia. Investigation of the biochemical basis showed a doubled glucokinase maximal velocity in Px islets, with no change in the glucokinase protein concentration after adjustment for the different ␤-cell mass in Px and sham islets. Hexokinase activity measured in islet extracts was also minimally increased, but the glucose 6-phosphate concentration and basal glucose usage of Px islets were not different from those in islets from sham-operated rats. The dominant ␤-cell adaptive response in the 60% Px rats was an increased catalytic activity of glucokinase. The remaining ␤-cells thus sense, and respond to, perceived hyperglycemia despite glycemia actually being normal. ␤-Cell mass and insulin secretion are both augmented so that whole pancreas insulin output, and consequently glycemia, are maintained at normal levels. glucokinase; glucose metabolism; glycolysis; glucose 6-phosphate; islets of Langerhans; insulin secretion THE ISLET ␤-CELL through its secretion of insulin regulates the storage and metabolism of cellular fuels. Not surprisingly, the regulatory system is complex, with multiple factors affecting insulin secretion, proinsulin synthesis, and the mass of pancreatic ␤-cells. The best studied factor is glucose; all of these functional aspects are glucose responsive, and it is well accepted that glycemia is the major regulator of ␤-cell function. However, the primary effect of ␤-cell activity is to maintain a normal metabolic milieu. When ␤-cells function normally, insulin secretion precisely meets tissue insulin needs so that normoglycemia is maintained (16). Moreover, whole body insulin sensitivity varies throughout life (puberty, pregnancy, and aging are insulin-resistant states), yet most humans do not develop diabetes. As such, an unanswered question in regard to the glucose homeostasis system is how ␤-cell adaptation occurs in the absence of ongoing changes in glycemia.
THE ISLET ␤-CELL through its secretion of insulin regulates the storage and metabolism of cellular fuels. Not surprisingly, the regulatory system is complex, with multiple factors affecting insulin secretion, proinsulin synthesis, and the mass of pancreatic ␤-cells. The best studied factor is glucose; all of these functional aspects are glucose responsive, and it is well accepted that glycemia is the major regulator of ␤-cell function. However, the primary effect of ␤-cell activity is to maintain a normal metabolic milieu. When ␤-cells function normally, insulin secretion precisely meets tissue insulin needs so that normoglycemia is maintained (16) . Moreover, whole body insulin sensitivity varies throughout life (puberty, pregnancy, and aging are insulin-resistant states), yet most humans do not develop diabetes. As such, an unanswered question in regard to the glucose homeostasis system is how ␤-cell adaptation occurs in the absence of ongoing changes in glycemia.
Insight has come from studies of rodents with geneticbased insulin resistance or pregnancy; their ␤-cells are supersensitive to glucose so that insulin secretion is augmented at normoglycemia (4, 6-8, 11, 30) . Kahn et al. (15) reported the same finding in healthy humans made insulin resistant by a 14-day nicotinic acid infusion. Thus a disassociation of the normal coupling between glucose concentration and insulin secretion characterizes the ␤-cell adaptation to insulin resistance. The mechanism of this effect is unknown. We studied nondiabetic insulin-resistant spontaneously hypertensive rats (SHR) and found that catalytic activity of the ␤-cell glucose sensor enzyme, glucokinase, was enhanced (6) . However, alternate mechanisms have been reported in other models (3, 34, 40) . In particular, a recent suggestion is that elevated ␤-cell fatty acid (FA) metabolism mediates the heightened glucose sensing for insulin secretion, because hypertriglyceridemia commonly is found with insulin resistance (32) , and culturing islets with FA shifts to the left the glucose concentration-insulin secretion curve (12, 28, 42) . It remains unclear how to reconcile these different findings.
Little is known about how glucose homeostasis is preserved when the ␤-cell mass is lowered. Biobreeding rats before onset of autoimmune diabetes have a leftshifted glucose concentration-insulin secretion curve (36) . We made the same observation after a 60% pancreatectomy in rats (20) . Thus a variable ␤-cell sensitivity to glucose also operates when the ␤-cell mass is lowered. Whether the biochemical details are the same as for insulin-resistant states is not known.
The current study investigated rats after a 60% pancreatectomy (Px); these rats maintain normal plasma levels of insulin and glucose despite the considerable loss of ␤-cells (14, 19, 29) , making them an excellent model for the investigation of ␤-cell adaptive mechanisms. Rats were studied 4 wk after the Px surgery to minimize any possibility that the observed changes were in transition and not reflective of the completed ␤-cell adaptation process.
METHODS

60% Px model and islet isolation.
One hundred-gram Sprague-Dawley rats underwent 60% Px by use of our previously described method (19) . Briefly, the portion of the pancreas bordered by the spleen and stomach extending to the small flap of pancreas attached to the pylorus was removed by use of gentle abrasion with cotton applicators. The removed portion was 57 Ϯ 3% of the pancreas weight (19) . Control (sham) rats underwent laparotomy and mobilization of the pancreas with gentle rubbing between the fingers. Postoperatively, all rats received standard chow and tap water ad libitum until being studied 4 wk after the surgery. Islets were isolated using an adaptation of the Gotoh method (10): pancreas duct infiltration with collagenase (Serva, Heidelberg, Germany), Histopaque gradient separation (Sigma, St. Louis, MO), and hand picking. Islet DNA content was measured by the Labarca method (17), protein by a commercial kit (Bio-Rad, Hercules, CA) with bovine albumin as standard, and insulin content after acid ethanol extraction with an insulin RIA (1). Freshly isolated islets were used in all experiments.
Oral glucose tolerance test and meal challenge. Both tests were preceded by an overnight fast. Px and sham rats were administered 1 g/kg of glucose (0.5 g/ml) by gavage tube. Blood for plasma glucose determination was obtained by tail snipping at 0, 30, 60, and 120 min. The meal challenge was performed 3 days later. Px and sham rats were given free access to chow at 9:00 AM (time 0), and plasma glucose values were measured at 0, 30, 60, and 120 min.
Islet insulin secretion and glucose utilization. Islets underwent 30 min of preincubation in warmed and oxygenated Krebs-Ringer buffer (KRB) with 2.8 mM glucose and 0.5% BSA. Insulin secretion was assessed using triplicate batches of 10 islets in glass vials containing 1 ml of KRB with 0.5% BSA and 2.8, 5.5, 8.3, or 16.7 mM glucose for 60 min in a 37°C shaking water bath. Medium was separated by gentle centrifugation and stored at Ϫ20°C pending insulin measurement by RIA (1). Islet glucose usage was measured as previously described (6) Islet glucokinase/hexokinase kinetics. Glucose phosphorylation was measured in islet extracts as previously described (6) with a method based on quantifying conversion of NAD ϩ to NADH by exogenous glucose-6-phosphate dehydrogenase (22) . Islet homogenates were centrifuged at 12,000 g for 10 min, and the supernatants were incubated at 10 glucose concentrations (0.03-100 mM) to measure glucose phosphorylation. Maximal velocity (V max ) and Michaelis-Menten constant (K m ) values for glucokinase and hexokinase were calculated by linear regression from an Eadie-Scatchard plot (volume/ substrate concn) and 10 cycles of the method of Spears et al. (35) to identify each enzyme's activity.
Glucokinase immunoblots. Glucokinase immunoblots were performed as described (6) using sheep antiserum raised against an Escherichia coli-derived B1 isoform of rat glucokinase (gift from Dr. Mark Magnuson, Vanderbilt University). Bound antibody was detected by chemiluminescence and quantified by densitometry. Islets used under denaturing conditions were homogenized in 80 mM Tris (pH 6.8), 0.5% NP-40, 0.5% Triton X, 5 mM EDTA, 0.2 mM N-ethylmaleimide, and 1 mM phenylmethylsulfonyl fluoride, followed by heating at 95°C for 5 min in Laemmli sample buffer that contained 2% SDS and by running on a 10% acrylamide gel with stacking and separating buffers that contained 0.4% SDS. Nondenaturing gels were performed using islets that were homogenized in 20 mM K 2 HPO 4 , 1 mM EDTA, 110 mM KCl, and 2 mM dithiothreitol, placed in Laemmli sample buffer without SDS, and run on a 15% acrylamide gel with buffers without SDS.
Islet glucose 6-phosphate concentration. Px and sham islets (20 per tube) were incubated in prewarmed and oxygenated KRB with 0.5% BSA and 2.8, 8.3, or 16.7 mM glucose for 60 min in a 37°C shaking water bath, followed by rapid lysis in 10 µl of 40 mM NaOH. Then they were placed on ice for 10 min, and 3 µl of 0.15 M HCl were added with incubation at 75°C for 20 min to destroy cellular enzymes to ensure stability of glucose 6-phosphate (G-6-P) content. G-6-P was measured using an adaptation of the Lowry and Passonneau method (24) as previously described (23).
Analytical methods. Plasma glucose was measured with a Beckman Glucose Analyzer II (Beckman, Fullerton, CA). The insulin RIA used charcoal separation (1) and rat insulin standards (Lilly, Indianapolis, IN). Plasma triglycerides and free fatty acids were measured by commercial kits (Sigma and Wako Chemicals, Richmond, VA, respectively).
Data analysis and statistical methods. Data are expressed as means Ϯ SE. The listed n values for the isolated islet data are the numbers of experiments that were performed using islets from separate isolation days. Islet data are expressed per protein or DNA content to adjust for the difference in cell mass of isolated islets from Px and sham rats. Western blots were performed using islets from single Px and sham rats, so the listed n value is the number of animals studied. The densitometry results from Western blots were expressed in relative terms by comparing the Px band on each gel to the sham band (assigned a value of 100%). Statistical significance was determined with the unpaired Student's t-test, except for the Western blot results, for which the one-tailed t-test was used.
RESULTS
General characteristics. Body weight and nonfasting glycemia, insulinemia, triglyceridemia, and plasma free fatty acids were equal in the 60% Px and shamoperated rats (Table 1 ). An oral glucose tolerance test and a meal challenge were performed to confirm the normoglycemia of the 60% Px rats; glycemic responses were identical in the two groups (Fig. 1) . One possibility for these results was regeneration of the excised ␤-cells. We had previously addressed that issue 7 wk after 60% Px: ␤-cell mass was 55% of the sham rats, which is a 40% increase from the postsurgery period, and islet non-␤-cell mass was unchanged at 45% of control, which suggests that the islet regeneration was ␤-cell specific (19) . We now report identical findings in isolated islets from 60% Px rats 4 wk after the surgery. Islet DNA, protein, and insulin content were 40% increased compared with the sham-operated animals (Table 2) . Consequently, the 60% Px induced some ␤-cell regeneration, but it was incomplete.
Islet glucose sensing/responsiveness. We assessed insulin secretion and glucose utilization in isolated islets from the 60% Px and sham-operated rats (Fig. 2) ; results are expressed per milligram of protein to compensate for the different islet cell mass. Both parameters showed an upregulated response in the Px islets, with no change in the dose giving a half-maximal response (ED 50 ), and a 70-80% increase at 8.4 mM glucose, which approximates the usual nonfasting plasma glucose level of the Px and sham rats ( Table 1) .
The pattern of the increase suggested augmented glucokinase activity in the Px islets, which was confirmed by measuring glucose phosphorylation in islet extracts over a range of 0.03-100 mM glucose ( Fig. 3 ; derived enzyme kinetics shown in Table 3 ). Glucose phosphorylation over the range of glucose concentrations that approximated normoglycemia was 60% increased in the Px islets, in close agreement with the results in Fig. 2 . The reason was a twofold increase in glucokinase V max (P Ͻ 0.002) with no change in ED 50 . Hexokinase V max also was somewhat increased. However, the absence of increased basal glucose usage in the Px islets (Fig. 2) suggested that its activity within the intact cell was not substantially changed. Neither was there a difference in G-6-P concentration between the Px and sham islets at 2.8, 8.3, and 16.7 mM glucose (Fig. 4) , which is a potent allosteric inhibitor of hexokinase (9) . The reason for the raised basal insulin secretion in the Px islets was thus not clear from these results.
Glucokinase immunoblot. Glucokinase immunoblots were performed in Px and sham islets; Fig. 5A shows a standard denaturing gel with samples from 2 Px and 2 sham rats. A small increase in glucokinase was noted in the Px islets, which averaged 142 Ϯ 12% of control (P Ͻ 0.02 based on 6 Px and 6 sham rats). However, the gels were performed using equivalent amounts of islet protein from Px and sham islets and thus failed to adjust for the 40% ␤-cell enrichment of the Px islets (Table 1) ; the close agreement between these figures suggested that the increased band intensity of the Px islets on immunoblot simply reflected differences in how much ␤-cell protein was loaded. Additional support for this conclusion is shown in Fig. 5B , which is a nondenaturing gel with comparable Px and sham islet extracts. Nondenaturing conditions leave relatively intact protein-protein interactions or allosteric influences that modulate a protein's function. Striking differences were seen compared with the denaturing gel; the Px band intensity was now less than that of the sham, confirming the presence of a glucokinase posttranslational change in Px islets. Thus the doubled glucokinase V max per kilogram DNA in the Px islets stemmed from an enhanced catalytic activity of this enzyme, as opposed to a changed ␤-cell expression.
DISCUSSION
This study has identified the ␤-cell adaptive responses in 60% Px rats that kept insulinemia, and thus glycemia and triglyceridemia, indistinguishable from sham-operated rats. One element was a limited regeneration of the excised ␤-cells, which brought the pancreas ␤-cell mass from 40% of normal at the time of surgery to slightly more than one-half of normal several weeks later (19) . The more consequential effect was a changed relationship between the glucose concentration and islet glucose utilization so that normal levels of glycemia elicited a raised flux of islet glucose metabolism, and consequently greater than normal insulin secretion. The latter reflects ␤-cell glycolytic flux being a key regulator of glucose-induced insulin secretion through well characterized effects on ␤-cell ion channels and membrane potential (27, 31) . The heightened glycolytic flux stemmed from an enhanced activity of glucokinase, which is the main regulator of ␤-cell glucose usage and is termed the ␤-cell glucose sensor (26) . The mechanism was an increased catalytic activity of this enzyme, as opposed to a change of its ␤-cell concentration, which was confirmed by the novel observation of divergent denaturing and nondenaturing glucokinase immunoblots in the Px islets. Crucial to the workings of this regulatory system was the observation that the degree of change in glucokinase activity was small; glucose phosphorylation and, consequently, glucose metabolism were 60-80% increased in Px islets at the physiologically relevant 8.4 mM glucose, compared with the multifold changes in gene expression that make up many cellular regulatory systems, such as the fivefold increase in proinsulin gene expression reported after short-term exposure of ␤-cells to a high glucose concentration (21) . The reason is that glucokinase is the rate-limiting ␤-cell glycolytic enzyme and is without allosteric or end-product influences (26, 27) . Its activity thus directly modulates ␤-cell glucose utilization and insulin secretion (38) . This effect was evident in the current study by the close agreement between the degree of changes in glucokinase activity, glucose utilization, and insulin secretion in the Px islets. As such, insulin release at 8.4 mM glucose also increased 80%, which is very significant physiologically. By this reasoning, it is of interest that the rise in ␤-cell mass to 55% of normal (19) , together with the 92% increased glucokinase activity per cell mass shown in Table 3 , results in whole pancreas glucokinase activity in the Px rats being identical to that in the sham rats. Our results are consistent with the recent study of Martín et al. (25) , which concluded that an upregulation of islet glucose metabolism was the basis for the ␤-cell glucose hypersensitivity in normoglycemic 60% Px mice, although the study provided no insight as to the mechanism (25) . Note, glucose utilization was assessed in this study only as conversion of H]glucose to [ 3 H]H 2 O, and a measure of affected pathways and metabolites is needed to fully understand how the change in glucokinase activity affects islet-cell glucose metabolism, analogous to the studies of others (38, 39) .
Our finding of increased glucokinase catalytic activity in the Px islets agrees with our studies of normoglycemic insulin-resistant SHR rats (6) and rats that were hyperinsulinemic and normoglycemic secondary to glucose infusions (5) . Making the same observation in three diverse rat models of successful ␤-cell adaptation suggests that variable glucokinase activity is a core ␤-cell adaptive response of the glucose homeostasis system that is initiated by changing metabolic demands for insulin secretion of multiple types. The basis for this effect is not known, although evidence for a Fig. 2. Insulin secretion (A, n ϭ 3 experiments) and glucose utilization (B, n ϭ 4 experiments) in isolated islets from rats 4 wk after 60% (r) or sham (s) pancreatectomy. Fig. 3 . Glucose phosphorylation (n ϭ 5 experiments) measured after 90-min incubations at the shown glucose concentrations in islet extracts from rats 4 wk after 60% (r) or sham (s) pancreatectomy. The reaction was measured at 30°C as the appearance of NADH from NAD ϩ by exogenous glucose-6-phosphate dehydrogenase. Left: incubations carried out at 0.03-0.5 mM glucose, primarily representing hexokinase activity; right: incubations carried out at 6-100 mM glucose, primarily representing glucokinase activity.
protein interaction affecting ␤-cell glucokinase activity has recently appeared (37) . However, this is not the only mechanism that alters ␤-cell glucose sensing in a compensatory fashion, because others have been identified in specialized states. Best studied is pregnancy, a state of insulin resistance, in which upregulation of ␤-cell glucokinase and hexokinase cellular levels occurs, presumably on the basis of the distinctive mediators prolactin and placental hormones (30, 34) . A second mode regards the compensatory hyperinsulinemia in models of insulin resistance with marked hypertriglyceridemia, which has been linked to high levels of islet FA metabolites (12, 28, 42) . We showed that the mechanism is increased activity of phosphofructokinase that lowers the G-6-P level through accelerated G-6-P metabolism (23) . G-6-P is a potent inhibitor of hexokinase (9), and our results thus focused on deinhibition of hexokinase as the basis for the enhanced basal ␤-cell glucose sensing and insulin secretion with excess FA. Viewed in toto, there is a repertoire of ␤-cell adaptive responses depending on the stimulus, which have in common an ability to alter insulin secretion through changes in the ␤-cell sensitivity to glucose and thus do not require a change in glycemia. The importance of this effect reflects the myriad of cellular dysfunctions attributed to chronic hyperglycemia (so-called glucose toxicity) (20, 33, 41) .
The above discussion has focused on normoglycemic states, i.e., when the ␤-cell adaptive mechanism is successful. Studies of hyperglycemic states have suggested that there is the occurrence of an additional element that affects ␤-cell glucose sensing. We studied 90% Px rats that develop mild hyperglycemia, and we observed that increased hexokinase V max was the dominant change affecting islet glucose phosphorylation (13) , in tandem with a substantial rise in basal insulin secretion (20) . We also studied 48-h glucose-infused rats and showed that islet hexokinase V max and basal insulin secretion were increased in hyperglycemic rats but not in those that were normoglycemic/hyperinsulinemic (5). Cockburn et al. (7) studied diabetes-prone Zucker diabetic fatty rats before and after the onset of diabetes; the prediabetes time point was characterized by increased islet glucokinase activity (analogous to our results in 60% Px rats), as opposed to hexokinase activity and basal insulin secretion being markedly increased when hyperglycemia was established (7). These results suggest that hyperglycemia or an associated metabolic defect upregulates ␤-cell hexokinase activity, and consequently basal insulin secretion, through an undefined mechanism. Moreover, we have argued that a hyperstimulated insulin secretion, leading to the ␤-cell insulin content falling below a required level for normal secretory responses, is a mechanism of ␤-cell dysfunction with chronic hyperglycemia (18) . It may be that this increased hexokinase activity is an important causative factor of this sequence.
In summary, our results provide an explanation for the conundrum regarding the glucose homeostasis system whereby ␤-cells are known to be glucose responsive at multiple functional levels, so that glycemia is considered their main regulatory influence, coupled with the understanding that glycemia varies little throughout life because of offsetting compensations of insulin secretion. The regulatory system observed herein is based on a changeable rate of ␤-cell glucose metabolism so that ␤-cells are ''tricked'' to perceive altered glycemia in the face of normoglycemia, allowing glucose-regulated ␤-cell Fig. 4 . Glucose 6-phosphate (G-6-P) concentration (n ϭ 3 experiments) of isolated islets from rats 4 wk after 60% (r) or sham (s) pancreatectomy. Freshly isolated islets were incubated in KRB and 2.8, 8.3, or 16.7 mM glucose for 60 min, followed by measurement of G-6-P content, as described in the text. 
